There are 22 papers on cervical dysplasia in aging research: 2 trials and 14 observational studies in people, 4 reviews.
22 papers study it5 more mention it5 findings
1 new paper in 30 daysSee all 27 papers on cervical dysplasia
“HR-HPV infection and dysplasia were associated with significantly higher Nugent scores (p = 0.001 and p = 0.008).”
- Human trial2
- Humans14
- In silico2
Interventions
1Estrogen
downin humans1
1 study
Estrogen
downin humans1
Estrogen decreases cervical dysplasia in humans (>90% resolution).
“Over 90% of participants experienced resolution of abnormal cytology within 4–6 months of initiating local estrogen therapy.”
Human triallocal vaginalcervix4–6 monthsfemalesn = 800
ENDO 2025 abstract
Associations
4Nugent score
upin humans1
1 study
Nugent score
upin humans1
Cervical dysplasia is associated with Nugent score in humans (apparently healthy women in Togo).
“HR-HPV infection and dysplasia were associated with significantly higher Nugent scores (p = 0.001 and p = 0.008).”
Humansapparently healthy women in Togovaginafemalesn = 338
Frontiers in endocrinology
Liquid-based cytology
upin humans1+100% sensitivity
1 study
Liquid-based cytology
upin humans1+100% sensitivity
Liquid-based cytology predicts cervical dysplasia in humans (HIV-positive females) (100% sensitivity).
“Liquid-Based Cytology demonstrated the highest sensitivity (100%) and negative predictive value, outperforming other screening methods.”
HumansHIV-positive femalesfemalesn = 250
JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH
CD4 count<500
upin humans1
1 study
CD4 count<500
upin humans1
CD4 count<500 is associated with cervical dysplasia in humans (HIV-positive females) (p<0.05).
“Risk factors significantly associated with abnormal cytology included age between 30-49 years, late menopause (46-50 years), higher parity, and CD4 count<500 (p<0.05).”
HumansHIV-positive femalesfemalesn = 250
JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH
Oncogenic human papillomavirus
upin humans1
1 study
Oncogenic human papillomavirus
upin humans1
oncogenic human papillomavirus is associated with cervical dysplasia in repeat HPV-positive women (50% (4/8)).
“Fifty per cent (4/8) of the women with a positive repeat test had dysplasia in histology.”
Humansin repeat HPV-positive womenfemalesn = 8
Infectious agents and cancer
Trial sponsors
Company2 trialsPhase 3404 people
1 trialPhase 2134 people
1 trial2,500 people